Document is current

Any future updates will be listed below

062 Pembrolizumab induced lambert-eaton myasthenic syndrome

Crossref DOI link: https://doi.org/10.1136/bmjno-2021-ANZAN.62

Published Online: 2021-08-23

Published Print: 2021-08

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark